195 related articles for article (PubMed ID: 36629681)
41. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
Abdulateef NA; Ismail MM; Aljedani H
Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
[TBL] [Abstract][Full Text] [Related]
42. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
Dorfman DM; Morgan EA; Pelton A; Unitt C
Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of myeloid antigens in patients of acute lymphoblastic leukaemia.
Jawad A; Khan SA; Uddin N; Ahmad D; Tipu HN; Akhtar F
J Pak Med Assoc; 2022 Mar; 72(3):424-429. PubMed ID: 35320218
[TBL] [Abstract][Full Text] [Related]
44. Flow cytometry with or without cytochemistry for the diagnosis of acute leukemias?
Kheiri SA; MacKerrell T; Bonagura VR; Fuchs A; Billett HH
Cytometry; 1998 Apr; 34(2):82-6. PubMed ID: 9579605
[TBL] [Abstract][Full Text] [Related]
45. [The features and significance of immunophenotyping in adult acute leukemia].
Pei MF; Zhang GS; Xiao L
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):262-4. PubMed ID: 12212161
[TBL] [Abstract][Full Text] [Related]
46. Immunophenotypic and cytogenetic changes in acute leukaemia at relapse.
Hur M; Chang YH; Lee DS; Park MH; Cho HI
Clin Lab Haematol; 2001 Jun; 23(3):173-9. PubMed ID: 11553058
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
48. Flow cytometric characterization of phenotype, DNA indices and p53 gene expression in 55 cases of acute leukemia.
Powari M; Varma N; Varma S; Marwaha RK; Sandhu H; Ganguly NK
Anal Quant Cytol Histol; 2002 Jun; 24(3):159-65. PubMed ID: 12102128
[TBL] [Abstract][Full Text] [Related]
49. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
Suggs JL; Cruse JM; Lewis RE
Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
[TBL] [Abstract][Full Text] [Related]
50. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
[TBL] [Abstract][Full Text] [Related]
52. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
53. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
54. Childhood T-acute lymphoblastic leukemia relapsed as minimally differentiated acute myeloid leukemia (AML-M0).
Ortín X; Escoda L; Nomdedeu J; Llorente A; Cabezudo E; Boixadera J; Ugarriza A
Leuk Lymphoma; 2003 Dec; 44(12):2159-61. PubMed ID: 14959865
[No Abstract] [Full Text] [Related]
55. Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome.
Alves GV; Fernandes AL; Freire JM; Paiva Ade S; Vasconcelos RC; Sales VS; Lemos TM; Gil EA; Freire FH; Cavalcanti e Silva DG; Maciel JF; Farkatt IG; Cavalcanti Júnior GB
J Clin Lab Anal; 2012 Nov; 26(6):431-40. PubMed ID: 23143625
[TBL] [Abstract][Full Text] [Related]
56. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
Piedras J; Barrales-Benítez O; López-Karpovitch X
Rev Invest Clin; 2000; 52(5):524-8. PubMed ID: 11195181
[TBL] [Abstract][Full Text] [Related]
57. [Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages].
Ma J; Liu YF; Chen SM; Zhang QT; Sun L; Liu LX; Wan DM; Chen SQ; Xie XS; Meng XL; Jiang ZX; Cheng YD; Wang F; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):942-5. PubMed ID: 20723305
[TBL] [Abstract][Full Text] [Related]
58. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
[TBL] [Abstract][Full Text] [Related]
59. How I Diagnose Acute Leukemia of Ambiguous Lineage.
Weinberg OK; Arber DA
Am J Clin Pathol; 2022 Jul; 158(1):27-34. PubMed ID: 35775438
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of Immunophenotypes in 329 Patients with B-ALL at Different Ages].
Zheng YH; Lin YF; Xu RY; Zhou YZ; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1225-30. PubMed ID: 26524013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]